Hypertension Diagnostics (OTCMKTS:HDII) & Mettler-Toledo International (NYSE:MTD) Critical Comparison

Hypertension Diagnostics (OTCMKTS:HDII) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Risk and Volatility

Hypertension Diagnostics has a beta of -0.66, indicating that its stock price is 166% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

Valuation & Earnings

This table compares Hypertension Diagnostics and Mettler-Toledo International”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hypertension Diagnostics	N/A	N/A	N/A	N/A	N/A
Mettler-Toledo International	$3.87 billion	7.84	$863.14 million	$40.10	37.04

Mettler-Toledo International has higher revenue and earnings than Hypertension Diagnostics.

Insider and Institutional Ownership

95.1% of Mettler-Toledo International shares are owned by institutional investors. 40.0% of Hypertension Diagnostics shares are owned by company insiders. Comparatively, 0.8% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Hypertension Diagnostics and Mettler-Toledo International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hypertension Diagnostics	N/A	N/A	N/A
Mettler-Toledo International	21.20%	-426.96%	26.03%

Analyst Ratings

This is a summary of current recommendations for Hypertension Diagnostics and Mettler-Toledo International, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hypertension Diagnostics	0	0	0	0	0.00
Mettler-Toledo International	0	7	6	0	2.46

Mettler-Toledo International has a consensus target price of $1,441.67, indicating a potential downside of 2.95%. Given Hypertension Diagnostics’ higher possible upside, equities analysts clearly believe Hypertension Diagnostics is more favorable than Mettler-Toledo International.

Summary

Mettler-Toledo International beats Hypertension Diagnostics on 7 of the 10 factors compared between the two stocks.

About Hypertension Diagnostics

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.

About Mettler-Toledo International

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.